Skip to content

Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

Comparative Study Between Prednisolone, Cerebrolysin in the Treatment of Bell's Palsy

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05821075
Enrollment
90
Registered
2023-04-20
Start date
2023-08-24
Completion date
2026-02-28
Last updated
2025-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bell Palsy

Brief summary

Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies. Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy

Interventions

DRUGPrednisolone

prednisolone 60mg tablet once daily for 5 days then tapering dose

DRUGCerebrolysin

intramuscular Cerebrolysin 10 mg daily for 3 weeks

Sponsors

October 6 University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* unilateral acute facial palsy of no identifiable cause

Exclusion criteria

* Recurrent facial Bell's palsy * Pregnancy * Diabetes * Epilepsy * Severe hypertension, * Renal or hepatic disease, * Gastric or duodenal ulcer * presence of acute otitis media or ipsilateral chronic otitis * Recent head injury, * psychiatric disease * If there is any contraindications for corticosteroids

Design outcomes

Primary

MeasureTime frame
change in scores of the house Brackman grading system HBat baseline, after 1 week, after 3 week
changes in scores of the Sunnybrook grading system.at baseline, after 1 week, after 3 week

Countries

Egypt

Contacts

Primary ContactEngy Wahsh
engywahsh@o6u.edu.eg01003095692
Backup Contactmohamed rez
Abdelmaksodm.mousa@hotmail.com01006904056

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026